Every clinical trial relies on data from its study participants to inform decisions regarding the safety and efficacy of a potential new treatment. Clinical trial sponsors rely on the data from laboratory tests to bring clear insights that advance studies. Labcorp Central Laboratory Services generates more clinical trial data than … The post What does a central lab do? 4 core services to know appeared first on Insights From Our Labs to Yours ..read more

There is pressure worldwide for better, faster access to biological alternatives to conventional crop protection chemicals (CPCs). The U.S. Environmental Protection Agency (EPA) is ahead of regions such as the European Union (EU) in revising its regulatory approaches for biopesticides and in having a division dedicated to them, namely, the … The post Faster access to biopesticide alternatives to conventional pesticides under the U.S. BPPD regulatory framework appeared first on Insights From Our Labs to Yours ..read more

The association of excessive alcohol consumption and liver disease is well documented. The effect on levels of alcohol consumption during the COVID-19 pandemic has more recently been investigated, Julien et al., (Hepatology 2022, Vol 75, Issue 6, 1480-1490) estimated that the one-year increase in alcohol consumption during the pandemic would … The post Alcohol-related liver disease: Inherent Challenges and Strategies for Successful Clinical Trial Conduct appeared first on Insights From Our Labs to Yours ..read more

When it comes to discoveries in oncology, cancer patients can’t wait, which means neither can you. At Labcorp Preclinical Oncology, we understand there are many steps, phases and regulations to wade through to get to a lead drug candidate—all while time is of the utmost importance. We are excited to … The post Program management services are now offered as part of Labcorp’s Preclinical Oncology Services appeared first on Insights From Our Labs to Yours ..read more

March is National Kidney Month, and we at Labcorp are committed to improving the renal health of patients worldwide. The field of nephrology clinical research has been steadily adding new interventional trials over the last five years at an average pace of 176 trials per year. This activity reflects the … The post Enabling better access to kidney disease trials appeared first on Insights From Our Labs to Yours ..read more

In December 2022, Labcorp and Biomakers signed an agreement that will positively impact thousands of cancer patients in Latin America through greater access to diagnostic molecular profiling and participation in clinical trials. We recently asked Nicolas Kirchuk (NK), CEO and co-founder of Biomakers, and Isagani Chico (IC), MD, VP, global … The post Innovative collaboration between Biomakers and Labcorp to provide greater access to oncology patients in Latin America appeared first on Insights From Our Labs to Yours ..read more

The news broke with an ominous headline: “Blots on a Field?” Superimposed over an eerie image of a scientist lit by the green glow of a light-box, was the phrase “image sleuth finds signs of fabrication in scores of Alzheimer’s articles, threatening a reigning theory of the disease.”1 This story … The post The true impact of alleged fraud on Alzheimer’s research appeared first on Insights From Our Labs to Yours ..read more

Immuno-oncology (IO) treatments are transforming cancer care, achieving remissions in previously intractable diseases and, as recent data show, achieving sustained anti-tumor immunity that can last up to 10 years after treatment. As an umbrella term, IO covers a diverse range of treatment modalities from simple monoclonal antibodies (mAbs) to cell-based … The post 3 ways to simplify nonclinical testing for your immuno-oncology treatments appeared first on Insights From Our Labs to Yours ..read more

JB Flinders, Senior Director, CVMER, Operational Strategy and Planning and Peter Alfinito, Executive Director, CVMER, Operational Strategy and Planning February is American Heart Month, and we at Labcorp are dedicated to improve the cardiovascular health of patients worldwide, as part of Labcorp’s mission to improve health and improve lives. This … The post Delivering solutions to the next generation of cardiovascular medicines appeared first on Insights From Our Labs to Yours ..read more

Welcome to the February 2023 Labcorp Drug Development Decentralized Clinical Trial (DCT) blog. With Rare Disease Day coming soon on February 28, we are going to focus on how patients, sites and investigators can benefit by improving the design and execution of rare disease trials. What is Rare Disease Day? … The post Improving access to rare disease trials by incorporating DCT elements appeared first on Insights From Our Labs to Yours ..read more